Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain
Por:
Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V and Ruiz-Villaverde, R
Publicada:
1 jun 2026
Ahead of Print:
1 nov 2025
Resumen:
Filiaciones:
Armario-Hita, JC:
Univ Cadiz, Hosp Univ Puerto Real, Dept Dermatol, Puerto Real, Spain
Galán-Gutierrez, M:
Hosp Univ Reina Sofia, Dept Dermatol, Cordoba, Spain
Pereyra-Rodríguez, JJ:
Hosp Univ Virgen Rocio, Seville, Spain
Univ Seville, Sch Med, Dept Med, Seville, Spain
Suarez-Pérez, J:
Hosp Univ Virgen Victoria, Dept Dermatol, Malaga, Spain
Rodríguez-Serna, M:
Hosp Univ La Fe, Dept Dermatol, Valencia, Spain
de Frutos, JO:
Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
:
Hosp Univ Germans Trias I Pujol, Dept Dermatol, Badalona, Spain
Serra-Baldrich, E:
Hosp Univ San Pau, Dept Dermatol, Barcelona, Spain
Figueras-Nar, I:
Hosp Univ Bellvitge, Dept Dermatol, Barcelona, Spain
Zaragoza-Ninet, V:
Hosp Gen Univ Valencia, Dept Dermatol, Valencia, Spain
Ruiz-Villaverde, R:
Hosp Univ San Cecilio, Dept Dermatol, Granada, Spain
Bronze
|